Concern about overnight hypoglycemic events drives decision-making for patients with type 1 diabetes. For persons with type 1 diabetes (T1D) fear of the overnight hypoglycemic event drives care ...
Statins are tried-and-true moneymakers, but they also come with their own set of safety concerns. Cardiovascular problems linked to the meds are nothing new, and scientists recently highlighted ...
AbbVie ($ABBV) is facing bad news for its hep C powerhouse Viekira Pak as it dukes it out for market share with Gilead Sciences ($GILD) in the hep C market ...
In January 2015, Advera Health released a Drug Safety Monitor analysis comparing the safety of then newly approved Hepatitis C drugs Viekira Pak to Harvoni and Solvaldi (hereafter just Harvoni). Our ...
In a study published in the Journal of Managed Care & Specialty Pharmacy, the authors present a rating system that includes downstream costs following treatment to estimate the real-world financial ...
TriNetX, which focuses on real-world research to help develop new therapies, acquired pharmacovigilance software maker Advera Health Analytics for an undisclosed price. With the deal, TriNetX gets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results